What is the management of neurostorming?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Neurostorming

The management of neurostorming requires prompt recognition and aggressive treatment of the underlying causes, including sedation, analgesia, and control of secondary brain insults to reduce morbidity and mortality.

Definition and Recognition

Neurostorming, also known as paroxysmal sympathetic hyperactivity (PSH), is characterized by episodes of:

  • Hypertension
  • Tachycardia
  • Tachypnea
  • Hyperthermia
  • Diaphoresis
  • Posturing
  • Increased muscle tone

Initial Management Approach

1. Sedation and Analgesia

  • First-line treatment: Continuous sedation rather than bolus administration to prevent hemodynamic instability 1
  • Avoid hypotensive sedative agents that could compromise cerebral perfusion
  • Options include:
    • Propofol
    • Midazolam (avoid bolus administration which can cause hypotension)
    • Opioid analgesics (continuous infusion preferred over bolus)

2. Control of Secondary Brain Insults

Temperature Management

  • Treat hyperthermia aggressively as it exacerbates raised intracranial pressure 1
  • Target normothermia
  • Use antipyretics and cooling measures

Blood Pressure Management

  • Maintain systolic blood pressure >110 mmHg to ensure adequate cerebral perfusion 1
  • For hypertensive episodes:
    • Increase sedation
    • Consider small boluses of labetalol 1

Respiratory Management

  • Ensure adequate oxygenation (avoid SaO2 <90%) 1
  • Control ventilation with endotracheal intubation and mechanical ventilation
  • Monitor end-tidal CO2 to maintain normocapnia 1

3. Intracranial Pressure (ICP) Management

If ICP monitoring is in place and shows elevated pressure:

  • Elevate head of bed 20-30 degrees to improve venous drainage 1
  • Consider osmotic therapy:
    • Mannitol
    • Hypertonic saline (10% NaCl has shown efficacy in reducing ICP) 2
  • Avoid hypo-osmolar fluids which may worsen cerebral edema 1

4. Specific Pharmacological Interventions for Neurostorming

  • Beta-blockers (propranolol) to control tachycardia and hypertension
  • Alpha-2 agonists (clonidine) to reduce sympathetic outflow
  • GABA-ergic agents (baclofen) for increased muscle tone
  • Bromocriptine for severe cases

Advanced Management Options

For refractory cases:

  • Consider barbiturate coma if ICP remains elevated despite first-line measures 3
  • Evaluate for surgical intervention if appropriate:
    • External ventricular drainage for hydrocephalus 1
    • Decompressive craniectomy for refractory intracranial hypertension 1

Monitoring During Management

  • Continuous vital signs monitoring
  • ICP monitoring in severe traumatic brain injury cases 1
  • Cerebral perfusion pressure calculation (CPP = MAP - ICP)
  • Consider transcranial Doppler to assess cerebral blood flow 1

Pitfalls and Caveats

  1. Misdiagnosis: Neurostorming can be confused with seizures, pain, withdrawal, or infection. Ensure proper diagnosis before treatment.

  2. Hypotension risk: Overly aggressive treatment of hypertension can lead to cerebral hypoperfusion. Maintain systolic BP >110 mmHg 1.

  3. Fluid management: Avoid both hypovolemia and excessive fluid administration. Target euvolemia with isotonic fluids 1.

  4. Medication interactions: Be aware of potential interactions between sedatives, analgesics, and other medications used in neurocritical care.

  5. Nursing interventions: Some nursing interventions may transiently increase ICP. Family presence, sedation administration, and repositioning have been associated with lower ICP in some studies 4.

The management of neurostorming requires a multidisciplinary approach in a specialized neurocritical care setting with experienced providers to optimize outcomes and reduce secondary brain injury.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of elevated intracranial pressure.

Clinical pharmacy, 1990

Research

Effects of nursing interventions on intracranial pressure.

American journal of critical care : an official publication, American Association of Critical-Care Nurses, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.